Shares of Alcentra Capital Corp (NASDAQ:ABDC) have been given an average recommendation of “Hold” by the seven analysts that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $12.25.
ABDC has been the subject of a number of analyst reports. Raymond James Financial raised shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a report on Thursday, January 11th. ValuEngine raised shares of Alcentra Capital from a “buy” rating to a “strong-buy” rating in a report on Friday, December 1st. Finally, UBS Group upgraded shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 11th.
Alcentra Capital (NASDAQ:ABDC) opened at $7.72 on Tuesday. The company has a market cap of $109.97, a PE ratio of 16.08 and a beta of 0.55. Alcentra Capital has a 1-year low of $7.00 and a 1-year high of $14.73.
Institutional investors have recently made changes to their positions in the stock. Caxton Corp acquired a new stake in shares of Alcentra Capital during the 4th quarter worth about $500,000. Stilwell Value LLC acquired a new stake in Alcentra Capital in the 4th quarter valued at about $8,701,000. Pacific Ridge Capital Partners LLC acquired a new stake in Alcentra Capital in the 4th quarter valued at about $1,171,000. Wasatch Advisors Inc. increased its position in Alcentra Capital by 151.5% in the 4th quarter. Wasatch Advisors Inc. now owns 85,813 shares of the asset manager’s stock valued at $720,000 after acquiring an additional 51,689 shares in the last quarter. Finally, Goldman Sachs Group Inc. acquired a new stake in Alcentra Capital in the 2nd quarter valued at about $219,000. Institutional investors and hedge funds own 34.09% of the company’s stock.
About Alcentra Capital
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.